Hematoma Following Primary Total Hip Arthroplasty: A Grave Complication

被引:44
作者
Mortazavi, S. M. Javad [1 ]
Hansen, Patricia [1 ]
Zmistowski, Benjamin [1 ]
Kane, Patrick W. [1 ]
Restrepo, Camilo [1 ]
Parvizi, Javad [1 ]
机构
[1] Thomas Jefferson Univ Hosp, Rothman Inst Orthoped, Philadelphia, PA USA
关键词
total hip arthroplasty; hematoma; complications; POSTOPERATIVE HEMATOMA; VENOUS THROMBOEMBOLISM; REPLACEMENT THERAPY; PULMONARY-EMBOLISM; KNEE; INFLAMMATION; TRANSFUSION; COAGULATION; PROPHYLAXIS; PREVENTION;
D O I
10.1016/j.arth.2012.07.033
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
Hematoma following primary total hip arthroplasty (THA) can require a return to the operating room. The purpose of this study was to uncover risk factors for hematoma and how it affects the outcome of THA. This case-control study identified 38 patients requiring reoperation due to hematoma following THA between 2000 and 2007. The 38 patients were matched with 117 patients without hematoma. The mean follow-up was 4.1 years (range, 2.1-9.6). Multivariate regression showed that blood loss, administration of fresh frozen plasma and Vitamin K, perioperative anticoagulation and hormonal therapy were independent predictors for hematoma formation. Chronic anticoagulation and autologous blood transfusion were independent risk factors for mortality. Hematoma itself was found to be an independent risk factor for adverse outcomes, increasing morbidity and mortality, despite adequate treatment. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:498 / 503
页数:6
相关论文
共 28 条
[1]
Failure of the American College of Chest Physicians-1A protocol for Lovenox in clinical outcomes for thromboembolic prophylaxis [J].
Burnett, R. Stephen J. ;
Clohisy, John C. ;
Wright, Rick W. ;
McDonald, Douglas J. ;
Shively, Robert A. ;
Givens, Stephanie A. ;
Barrack, Robert L. .
JOURNAL OF ARTHROPLASTY, 2007, 22 (03) :317-324
[2]
Sciatic nerve palsy secondary to postoperative haematoma in primary total hip replacement [J].
Butt, AJ ;
McCarthy, T ;
Kelly, IP ;
Glynn, T ;
McCoy, G .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2005, 87B (11) :1465-1467
[3]
A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[4]
Re-admission rates within 28 days of total hip replacement [J].
Cullen, C. ;
Johnson, D. S. ;
Cook, G. .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2006, 88 (05) :475-478
[5]
Prevention of venous thromboembolic disease following primary total knee arthroplasty - A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin [J].
Fitzgerald, RH ;
Spiro, TE ;
Trowbridge, AA ;
Gardiner, GA ;
Whitsett, TL ;
O'Connell, MB ;
Ohar, JA ;
Young, TR .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2001, 83A (06) :900-906
[6]
A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty [J].
Freedman, KB ;
Brookenthal, KR ;
Fitzgerald, RH ;
Williams, S ;
Lonner, JH .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2000, 82A (07) :929-938
[7]
Early Return to Surgery for Evacuation of a Postoperative Hematoma After Primary Total Knee Arthroplasty [J].
Galat, Daniel D. ;
McGovern, Scott C. ;
Hanssen, Arlen D. ;
Larson, Dirk R. ;
Harrington, Jeffrey R. ;
Clarke, Henry D. .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2008, 90A (11) :2331-2336
[8]
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia [J].
Gebara, OCE ;
Mittleman, MA ;
Walsh, BW ;
Lipinska, I ;
Welty, FK ;
Bellotti, G ;
Muller, JE ;
Sacks, FK ;
Tofler, GH .
HEART, 1998, 80 (03) :235-239
[9]
Prevention of venous thromboembolism [J].
Geerts, William H. ;
Bergqvist, David ;
Pineo, Graham F. ;
Heit, John A. ;
Samama, Charles M. ;
Lassen, Michael R. ;
Colwell, Clifford W. .
CHEST, 2008, 133 (06) :381S-453S
[10]
Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range [J].
Hirsh, J ;
Dalen, JE ;
Anderson, DR ;
Poller, L ;
Bussey, H ;
Ansell, J ;
Deykin, D .
CHEST, 2001, 119 (01) :8S-21S